Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
Yulia Kiyan(Medizinische Hochschule Hannover), Hermann Haller(Medizinische Hochschule Hannover)
Cited by 61
Related Papers
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
|Nephrology Dialysis Transplantation|2019|216
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
|Nephrology Dialysis Transplantation|2020|189
CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling
|Cell Death and Disease|2016|42
Urokinase Receptor Associates With Myocardin to Control Vascular Smooth Muscle Cells Phenotype in Vascular Disease
|Arteriosclerosis Thrombosis and Vascular Biology|2011|33